These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17803431

  • 21. Penetration of moxifloxacin through crosslinked corneas.
    Litvin G, Ben Eliahu S, Rotenberg M, Marcovich AL, Zadok D, Kleinmann G.
    J Cataract Refract Surg; 2014 Jul; 40(7):1177-81. PubMed ID: 24878254
    [Abstract] [Full Text] [Related]

  • 22. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ, Yu AL, Holland GN, Ramaswamy A, Taban R, Mondino BJ, Yu F, Rayner SA, Giese MJ.
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [Abstract] [Full Text] [Related]

  • 23. The use of the African green monkey as a preclinical model for ocular pharmacokinetic studies.
    Glogowski S, Ward KW, Lawrence MS, Goody RJ, Proksch JW.
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):290-8. PubMed ID: 22235843
    [Abstract] [Full Text] [Related]

  • 24. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
    Donnenfeld ED, Comstock TL, Proksch JW.
    J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
    [Abstract] [Full Text] [Related]

  • 25. Amniotic membrane, tear film, corneal, and aqueous levels of ofloxacin in rabbit eyes after amniotic membrane transplantation.
    Kim HS, Sah WJ, Kim YJ, Kim JC, Hahn TW.
    Cornea; 2001 Aug; 20(6):628-34. PubMed ID: 11473165
    [Abstract] [Full Text] [Related]

  • 26. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Robertson SM, Curtis MA, Schlech BA, Rusinko A, Owen GR, Dembinska O, Liao J, Dahlin DC.
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309
    [Abstract] [Full Text] [Related]

  • 27. 193-nm excimer laser-induced fluorescence detection of fluoroquinolones in rabbit corneas.
    Chuck RS, Shehada RE, Taban M, Tungsiripat T, Sweet PM, Mansour HN, Grundfest WS, McDonnell PJ.
    Arch Ophthalmol; 2004 Nov; 122(11):1693-9. PubMed ID: 15534132
    [Abstract] [Full Text] [Related]

  • 28. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
    Yoshida J, Kim A, Pratzer KA, Stark WJ.
    J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
    [Abstract] [Full Text] [Related]

  • 29. Aqueous penetration of orally and topically administered moxifloxacin.
    Sharma T, Kamath MM, Kamath MG, Nayak RR, Bairy KL, Musmade PB.
    Br J Ophthalmol; 2015 Sep; 99(9):1182-5. PubMed ID: 25824259
    [Abstract] [Full Text] [Related]

  • 30. Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin.
    Durairaj C, Kadam RS, Chandler JW, Hutcherson SL, Kompella UB.
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5804-16. PubMed ID: 20484584
    [Abstract] [Full Text] [Related]

  • 31. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
    [Abstract] [Full Text] [Related]

  • 32. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
    Walters T, Rinehart M, Krebs W, Holdbrook M.
    Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
    [Abstract] [Full Text] [Related]

  • 33. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [Abstract] [Full Text] [Related]

  • 34. Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes.
    Yamada M, Ishikawa K, Mochizuki H, Kawai M.
    Acta Ophthalmol Scand; 2006 Apr; 84(2):192-6. PubMed ID: 16637835
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.
    Stewart WC, Crean CS, Zink RC, Brubaker K, Haque RM, Hwang DG.
    Am J Ophthalmol; 2010 Nov; 150(5):744-751.e2. PubMed ID: 20813346
    [Abstract] [Full Text] [Related]

  • 36. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits.
    Iyer GR, Cason MM, Womble SW, Li G, Chastain JE.
    J Ocul Pharmacol Ther; 2015 May; 31(4):204-10. PubMed ID: 25775192
    [Abstract] [Full Text] [Related]

  • 37. Ocular penetration of topically applied 1% daptomycin in a rabbit model.
    Sakarya R, Sakarya Y, Ozcimen M, Kesli R, Alpfidan I, Kara S.
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):75-8. PubMed ID: 23020811
    [Abstract] [Full Text] [Related]

  • 38. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.
    Yenice I, Mocan MC, Palaska E, Bochot A, Bilensoy E, Vural I, Irkeç M, Hincal AA.
    Exp Eye Res; 2008 Sep; 87(3):162-7. PubMed ID: 18675411
    [Abstract] [Full Text] [Related]

  • 39. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
    Zhang J, Wang L, Gao C, Zhang L, Xia H.
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of chlorhexidine gluconate 0.02% in the rabbit cornea.
    Xuguang S, Yanchuang L, Feng Z, Shiyun L, Xiaotang Y.
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):227-30. PubMed ID: 16910862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.